Fidelity Investments’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-19,230
| Closed | -$904K | – | 5577 |
|
|
2025
Q2 | $904K | Sell |
19,230
-11,185,569
| -100% | -$498M | ﹤0.01% | 2755 |
|
|
2025
Q1 | $494M | Buy |
11,204,799
+46,839
| +0.4% | +$2.16M | 0.03% | 458 |
|
|
2024
Q4 | $403M | Buy |
11,157,960
+17,014
| +0.2% | +$594K | 0.02% | 560 |
|
|
2024
Q3 | $357M | Buy |
11,140,946
+28,555
| +0.3% | +$1.07M | 0.02% | 600 |
|
|
2024
Q2 | $419M | Buy |
11,112,391
+44,365
| +0.4% | +$1.87M | 0.03% | 508 |
|
|
2024
Q1 | $545M | Buy |
11,068,026
+258,791
| +2% | +$12M | 0.04% | 428 |
|
|
2023
Q4 | $395M | Buy |
10,809,235
+1,423,764
| +15% | +$37.2M | 0.03% | 494 |
|
|
2023
Q3 | $214M | Buy |
9,385,471
+6,956
| +0.1% | +$190K | 0.02% | 670 |
|
|
2023
Q2 | $243M | Buy |
9,378,515
+3,698
| +0% | +$97.2K | 0.02% | 651 |
|
|
2023
Q1 | $238M | Buy |
9,374,817
+14,727
| +0.2% | +$430K | 0.02% | 641 |
|
|
2022
Q4 | $240M | Sell |
9,360,090
-70
| -0% | -$1.73K | 0.02% | 623 |
|
|
2022
Q3 | $263M | Buy |
9,360,160
+1,948,120
| +26% | +$55.9M | 0.03% | 576 |
|
|
2022
Q2 | $182M | Buy |
7,412,040
+1,365,831
| +23% | +$49.9M | 0.02% | 729 |
|
|
2022
Q1 | $341M | Buy |
6,046,209
+2,099,889
| +53% | +$120M | 0.03% | 574 |
|
|
2021
Q4 | $245M | Sell |
3,946,320
-68,800
| -2% | -$4.55M | 0.02% | 722 |
|
|
2021
Q3 | $255M | Buy |
4,015,120
+46,900
| +1% | +$3.61M | 0.02% | 701 |
|
|
2021
Q2 | $327M | Buy |
3,968,220
+176,852
| +5% | +$13.4M | 0.03% | 619 |
|
|
2021
Q1 | $279M | Buy |
3,791,368
+413,348
| +12% | +$32.4M | 0.02% | 644 |
|
|
2020
Q4 | $245M | Buy |
3,378,020
+1,808,508
| +115% | +$116M | 0.02% | 665 |
|
|
2020
Q3 | $74.8M | Buy |
1,569,512
+825,400
| +111% | +$35.2M | 0.01% | 1052 |
|
|
2020
Q2 | $31.3M | Sell |
744,112
-157,300
| -17% | -$5.6M | ﹤0.01% | 1362 |
|
|
2020
Q1 | $24.3M | Sell |
901,412
-209,700
| -19% | -$6.84M | ﹤0.01% | 1322 |
|
|
2019
Q4 | $42.8M | Hold |
1,111,112
| – | – | ﹤0.01% | 1274 |
|
|
2019
Q3 | $24.1M | Buy |
+1,111,112
| New | +$26.3M | ﹤0.01% | 1499 |
|
Other funds holding SWTX
Fidelity Investments's SWTX Position: Q3 2025 in Review
Fidelity Investments sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 19,230 shares — an estimated $904K sold.
Fidelity Investments first reported a position in SWTX in Q3 2019 and held it in 24 quarters. The position peaked at $545M in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- Fidelity Investments reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- Fidelity Investments sold 19,230 SpringWorks Therapeutics shares in Q3 2025, an estimated $904K.
- Fidelity Investments first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 24 quarters.
- Fidelity Investments's SpringWorks Therapeutics position peaked at $545M in Q1 2024.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.